BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21724695)

  • 1. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
    Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
    J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
    Baecklund E; Sundström C; Ekbom A; Catrina AI; Biberfeld P; Feltelius N; Klareskog L
    Arthritis Rheum; 2003 Jun; 48(6):1543-50. PubMed ID: 12794821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
    Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
    Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
    Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
    J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
    Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
    Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised serum APRIL levels in patients with systemic lupus erythematosus.
    Koyama T; Tsukamoto H; Miyagi Y; Himeji D; Otsuka J; Miyagawa H; Harada M; Horiuchi T
    Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
    Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
    Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
    Kobayashi S; Ikari K; Kaneko H; Kochi Y; Yamamoto K; Shimane K; Nakamura Y; Toyama Y; Mochizuki T; Tsukahara S; Kawaguchi Y; Terai C; Hara M; Tomatsu T; Yamanaka H; Horiuchi T; Tao K; Yasutomo K; Hamada D; Yasui N; Inoue H; Itakura M; Okamoto H; Kamatani N; Momohara S
    Arthritis Rheum; 2008 Jul; 58(7):1940-6. PubMed ID: 18576330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
    Minowa K; Amano H; Nakano S; Ando S; Watanabe T; Nakiri Y; Amano E; Tokano Y; Morimoto S; Takasaki Y
    Autoimmunity; 2011 Aug; 44(5):357-62. PubMed ID: 21320038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL.
    Nagatani K; Itoh K; Nakajima K; Kuroki H; Katsuragawa Y; Mochizuki M; Aotsuka S; Mimori A
    Arthritis Rheum; 2007 Nov; 56(11):3554-63. PubMed ID: 17968879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
    Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
    Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Portales-Cervantes L; Niño-Moreno P; Doníz-Padilla L; Baranda-Candido L; García-Hernández M; Salgado-Bustamante M; González-Amaro R; Portales-Pérez D
    Hum Immunol; 2010 Aug; 71(8):818-25. PubMed ID: 20493226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.
    Lin SC; Yen JH; Tsai JJ; Tsai WC; Ou TT; Liu HW; Chen CJ
    Arthritis Rheum; 2004 Mar; 50(3):770-5. PubMed ID: 15022318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
    Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.